Questions Remain When Treating Patients With CLL
Alexey Danilov, MD, PhD, explains the unmet needs for patients with relapsed/refractory chronic lymphocytic leukemia.
Emerging Research in the Chronic Lymphocytic Leukemia Space
Alexey Danilov, MD, PhD, provides an overview on the recent updates and research in the chronic lymphocytic leukemia space.
Ongoing Studies in CLL Look Towards New Treatment Options
Alexey Danilov, MD, PhD, discusses some targeted therapies being investigated in the relapsed/refractory chronic lymphocytic leukemia space.
Discussing the Treatment Landscape for CLL
Alexey Danilov, MD, PhD, discusses the current treatment landscape for chronic lymphocytic leukemia and how it has evolved.
Follow-Up Shows Venetoclax Plus Rituximab has Long-Term Efficacy in CLL
Alexey V. Danilov, MD, PhD, discusses a treatment regimen of venetoclax plus rituximab used for patients with chronic lymphocytic leukemia the 2019 American Society of Hematology Annual Meeting.
Current Regimens Being Investigated in Chronic Lymphocytic Leukemia
Alexey V. Danilov, MD, PhD, discusses important studies in the chronic lymphocytic leukemia space and questions whether combination or sequential therapy is better for patients with chronic lymphocytic leukemia.
